tpst-1495,pembrolizumab
tempest,merck
['tpst-1495 ', 'hanna', 'solid tumor', 'tpst-1495', 'pembro']
susanna ulahannan, m.d., presenting a phase 1 study of tpst-1495 as a single agent and in combination with pembrolizumab in patients with advanced solid tumors. #asco23 
@OUHealth Stephenson Cancer Center is Oklahoma's only National Cancer Institute-Designated Cancer Center.